Actively Recruiting

Phase Not Applicable
Age: 40Years - 80Years
All Genders
NCT07390825

Evaluation of the Effects of Aquatic Therapy on Activities of Daily Living, Walking, Balance, Posture, Pain, and Depression in Parkinson's Patients

Led by Ankara City Hospital Bilkent · Updated on 2026-02-05

42

Participants Needed

2

Research Sites

82 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms such as bradykinesia, tremors, and postural instability, as well as various non-motor symptoms. Conventional land-based rehabilitation is standard; however, aquatherapy-utilizing water's buoyancy, hydrostatic pressure, and viscosity-offers a promising alternative to improve balance and mobility while reducing fall risks. This study aims to evaluate the effects of aquatherapy on gait, balance, posture, freezing of gait, activities of daily living (ADL), pain, and depression in Turkish PD patients. This is a prospective, single-blind, randomized controlled trial involving 42 patients at Ankara City Hospital. Participants will be divided into two groups: * Group 1 (Control): Home-based exercise program (5 days/week for 6 weeks). * Group 2 (Intervention): Home-based exercises plus supervised aquatherapy (3 sessions/week, 45 minutes each, in a 30-32°C pool). The study utilizes high-tech objective measurements and validated scales: * Gait \& Posture: Zebris Gait Analysis (spatiotemporal parameters) and Diers Formetric 4D (topographical posture analysis). * Balance: HUR-Smart Balance device and the Berg Balance Scale. * Clinical Scales: PDQ-39 (quality of life), Freezing of Gait Questionnaire, Falls Efficacy Scale, MMSE (cognitive), Beck Depression Inventory, and VAS (pain). This research is noteworthy as the first aquatherapy study among Turkish PD patients to utilize a large sample size and standardized aquatic exercise protocols. It seeks to provide a comprehensive analysis of both motor and non-motor improvements, potentially establishing aquatherapy as a superior adjunctive treatment for enhancing functional independence in Parkinson's patients. Primary hypothesis or outcome measure : Parkinson's Disease Questionnaire-39 . PDQ-39 is a patient-reported outcome measure designed to evaluate the health-related quality of life in Parkinson's patients across eight specific domains, including mobility, activities of daily living, and emotional well-being.

CONDITIONS

Official Title

Evaluation of the Effects of Aquatic Therapy on Activities of Daily Living, Walking, Balance, Posture, Pain, and Depression in Parkinson's Patients

Who Can Participate

Age: 40Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with Idiopathic Parkinson's Disease and aged between 40 and 80 years
  • Regularly followed by a neurologist with stable medical treatment for at least 3 months
  • Disease stage between 1 and 3 according to the Modified Hoehn-Yahr Staging Scale
  • Mini-Mental State Examination (MMSE) score of 24 or higher
  • Ability to stand and walk independently or with assistance
Not Eligible

You will not qualify if you...

  • Orthopedic, rheumatological, or non-Parkinson's neurological disorders affecting function
  • Medical treatment changes in the last 3 months
  • Diagnosis of Atypical Parkinson's Disease
  • Visual impairment
  • Presence of dementia
  • Decompensated cardiac or respiratory failure
  • Diabetes insipidus
  • Systemic infection
  • Skin infections or impaired skin integrity
  • Increased sensitivity to inhaled steam or pool chemicals
  • History of epilepsy or asthma
  • Urinary or fecal incontinence
  • Refusal or inability to consent or participate in treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Bilkent City Hospital

Çankaya, Ankara, Turkey (Türkiye), 06800

Actively Recruiting

2

Bilkent City Hospital

Ankara, ÇANKAYA, Turkey (Türkiye), 06800

Actively Recruiting

Loading map...

Research Team

D

Duygu Yanıktaş, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here